Value of serum epidermal growth factor receptor in the selection of patients with non-small-cell lung cancer to be treated with the tyrosine kinase inhibitor erlotinib

Data de publicación
2012Título da revista
FEBS Journal
Tipo de contido
Publicación de congreso
